Your session is about to expire
← Back to Search
marcaine and kenalog for Pelvic Organ Prolapse
Phase 4
Waitlist Available
Research Sponsored by Kettering Health Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks postoperative
Awards & highlights
Study Summary
This trialwill study if an injection of anesthetic and steroid can reduce post-surgical pain, use of pain meds, and improve gluteal and sciatic pain scores after a ligament colpopexy.
Eligible Conditions
- Pelvic Organ Prolapse
- Postoperative Pain
- Trigger Point Injection
- Sacrospinous Ligament Fixation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks postoperative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks postoperative
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
objective pain score
Secondary outcome measures
subjective pain score rating
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Surgery Plus Trigger Point InjectionExperimental Treatment1 Intervention
Patient will have sacrospinous ligament suspension procedure with addition of a trigger point injection (9cc of 0.5% marcaine and 1 cc kenalog) over area of suture placement
Group II: Surgery AloneActive Control1 Intervention
Patient will receive sacrospinous ligament suspension surgery without any additional interventions
Find a Location
Who is running the clinical trial?
Kettering Health NetworkLead Sponsor
19 Previous Clinical Trials
1,838 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger